Compounds > 1,4-phenylenebis(methylene)selenocyanate
Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Adenomatous Polyposis Coli

1,4-phenylenebis(methylene)selenocyanate has been researched along with Adenomatous Polyposis Coli in 1 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Adenomatous Polyposis Coli: A polyposis syndrome due to an autosomal dominant mutation of the APC genes (GENES, APC) on CHROMOSOME 5. The syndrome is characterized by the development of hundreds of ADENOMATOUS POLYPS in the COLON and RECTUM of affected individuals by early adulthood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rao, CV1
Cooma, I1
Rodriguez, JG1
Simi, B1
El-Bayoumy, K1
Reddy, BS1

Other Studies

1 other study available for 1,4-phenylenebis(methylene)selenocyanate and Adenomatous Polyposis Coli

ArticleYear
Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate.
    Carcinogenesis, 2000, Volume: 21, Issue:4

    Topics: Adenomatous Polyposis Coli; Animals; Anticarcinogenic Agents; beta Catenin; Cyclooxygenase 1; Cycloo

2000